Cargando…

Human papillomavirus (HPV) deregulation of Toll-like receptor 9

Persistent infection by high-risk human papillomavirus (HPV) is associated with cervical carcinoma. Blocking innate immune responses in the cervix is critical for the establishment of persistent infections. Here, we discuss how HPV-16-encoded factors suppress the activity of Toll-like receptor 9, wh...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hasan, Uzma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935924/ https://www.ncbi.nlm.nih.gov/pubmed/24605267 http://dx.doi.org/10.4161/onci.27257

Ejemplares similares

The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Toll-like receptor genetic variants and colorectal cancer
por: Weber, Alexander NR, et al.
Publicado: (2014)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis
por: Kauppila, Joonas H., et al.
Publicado: (2013)

Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma
por: Rosa, Roberta, et al.
Publicado: (2013)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
por: Chew, Valerie, et al.
Publicado: (2013)

The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma
por: Horton, Jaime S, et al.
Publicado: (2014)

The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma
por: Sung, Wen-Wei, et al.
Publicado: (2013)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Immunotherapy of HPV-associated head and neck cancer: Critical parameters
por: Nizard, Mevyn, et al.
Publicado: (2013)

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
por: Pai, Sara I.
Publicado: (2013)

When defense turns into attack: Antiviral cytidine deaminases linked to somatic mutagenesis in HPV-associated cancer
por: Henderson, Stephen, et al.
Publicado: (2014)

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9(®) to better battle prostate cancer progression
por: Izumi, Kouji, et al.
Publicado: (2013)

Toll‐like receptors matter: plasmacytoid dendritic cells in COVID‐19
por: Becker, Jennifer, et al.
Publicado: (2022)

S100A9 and tumor growth
por: Leanderson, Tomas, et al.
Publicado: (2012)

Coevolutionary Analysis Implicates Toll-Like Receptor 9 in Papillomavirus Restriction
por: King, Kelly, et al.
Publicado: (2022)

The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
por: Hasan, Uzma A., et al.
Publicado: (2013)

Ferroptosis-like death in plant cells
por: Conlon, Megan, et al.
Publicado: (2017)

Utilizing T(H)9 cells as a novel therapeutic strategy for malignancies
por: Lu, Yong, et al.
Publicado: (2013)

HectH9 hijacks glucose metabolism to fuel tumor growth
por: Lee, Hong-Jen, et al.
Publicado: (2019)

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015)

Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy
por: Lu, Yong, et al.
Publicado: (2014)

Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013)

Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma
por: Gelb, Tara, et al.
Publicado: (2014)

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate “altered” cells?
por: Sommariva, Michele, et al.
Publicado: (2012)

JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia
por: de Bock, Charles E., et al.
Publicado: (2018)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

T cell receptor-therapy in HBV-related hepatocellularcarcinoma
por: Bertoletti, Antonio, et al.
Publicado: (2015)

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
por: Kmiecik, Justyna, et al.
Publicado: (2014)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014)

The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression
por: Basso, Daniela, et al.
Publicado: (2013)

PTHrP, its receptor, and protein kinase A activation in osteosarcoma
por: Walkley, Carl R, et al.
Publicado: (2014)

Extending the chimeric receptor-based T-cell targeting strategy to solid tumors
por: Rossig, Claudia
Publicado: (2013)

DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013)

Moving nuclear receptor Nur77 to damaged mitochondria for clearance by mitophagy
por: Hu, Mengjie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8f6j9tv0eihnn7op65jt9dj3u4